immunofluorescently stained cells Search Results


immunofluorescently stained cells  (Human Protein Atlas)
90
Human Protein Atlas immunofluorescently stained cells
Immunofluorescently Stained Cells, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunofluorescently stained cells/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunofluorescently stained cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
axiovision version 4.6 software suite  (Carl Zeiss)
90
Carl Zeiss axiovision version 4.6 software suite
Axiovision Version 4.6 Software Suite, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axiovision version 4.6 software suite/product/Carl Zeiss
Average 90 stars, based on 1 article reviews
axiovision version 4.6 software suite - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
immunohistochemistry and immunofluorescent staining of liver tissue slides  (PRIMACYT Cell Culture Technology GmbH)
90
PRIMACYT Cell Culture Technology GmbH immunohistochemistry and immunofluorescent staining of liver tissue slides
Immunohistochemistry And Immunofluorescent Staining Of Liver Tissue Slides, supplied by PRIMACYT Cell Culture Technology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry and immunofluorescent staining of liver tissue slides/product/PRIMACYT Cell Culture Technology GmbH
Average 90 stars, based on 1 article reviews
immunohistochemistry and immunofluorescent staining of liver tissue slides - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
genome-wide analysis of major subcellular localization information of human proteins based on immunofluorescent stained cells  (Human Protein Atlas)
90
Human Protein Atlas genome-wide analysis of major subcellular localization information of human proteins based on immunofluorescent stained cells
Genome Wide Analysis Of Major Subcellular Localization Information Of Human Proteins Based On Immunofluorescent Stained Cells, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genome-wide analysis of major subcellular localization information of human proteins based on immunofluorescent stained cells/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
genome-wide analysis of major subcellular localization information of human proteins based on immunofluorescent stained cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
life cell immunofluorescence staining  (LifeCell Inc)
90
LifeCell Inc life cell immunofluorescence staining
Life Cell Immunofluorescence Staining, supplied by LifeCell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/life cell immunofluorescence staining/product/LifeCell Inc
Average 90 stars, based on 1 article reviews
life cell immunofluorescence staining - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
immunofluorescent staining for both b cells (red, pax5 + ) and t cells (green, cd3)  (Wolters Kluwer Health)
90
Wolters Kluwer Health immunofluorescent staining for both b cells (red, pax5 + ) and t cells (green, cd3)
Immunofluorescent Staining For Both B Cells (Red, Pax5 + ) And T Cells (Green, Cd3), supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunofluorescent staining for both b cells (red, pax5 + ) and t cells (green, cd3)/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
immunofluorescent staining for both b cells (red, pax5 + ) and t cells (green, cd3) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cell staining for immunofluorescence microscopy  (Becton Dickinson)
90
Becton Dickinson cell staining for immunofluorescence microscopy
Cell Staining For Immunofluorescence Microscopy, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell staining for immunofluorescence microscopy/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cell staining for immunofluorescence microscopy - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
immunofluorescence staining images of human cancer cell lines pc-3  (Human Protein Atlas)
90
Human Protein Atlas immunofluorescence staining images of human cancer cell lines pc-3
(A) Genomic alteration profiles of NCBP1, <t>NCBP2,</t> NCBP3, NCBP2-AS1, NCBP2AS2 and NCBP2L in TCGA pan-cancer cohort. (B–C) Kaplan–Meier survival analysis showed OS (B) and DFS (C) in all pan-cancer patients divided by NCBP2 altered or unaltered groups. (D) The genomic alteration of NCBP2 in TCGA pan-cancer atlas, including mutation, amplification, deep deletion and multiple alterations.
Immunofluorescence Staining Images Of Human Cancer Cell Lines Pc 3, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunofluorescence staining images of human cancer cell lines pc-3/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunofluorescence staining images of human cancer cell lines pc-3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
confocal images of immunofluorescently stained cells  (Human Protein Atlas)
90
Human Protein Atlas confocal images of immunofluorescently stained cells
(A) Genomic alteration profiles of NCBP1, <t>NCBP2,</t> NCBP3, NCBP2-AS1, NCBP2AS2 and NCBP2L in TCGA pan-cancer cohort. (B–C) Kaplan–Meier survival analysis showed OS (B) and DFS (C) in all pan-cancer patients divided by NCBP2 altered or unaltered groups. (D) The genomic alteration of NCBP2 in TCGA pan-cancer atlas, including mutation, amplification, deep deletion and multiple alterations.
Confocal Images Of Immunofluorescently Stained Cells, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/confocal images of immunofluorescently stained cells/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
confocal images of immunofluorescently stained cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
direct immunofluorescence staining cells lyse/no-wash procedure  (Becton Dickinson)
90
Becton Dickinson direct immunofluorescence staining cells lyse/no-wash procedure
(A) Genomic alteration profiles of NCBP1, <t>NCBP2,</t> NCBP3, NCBP2-AS1, NCBP2AS2 and NCBP2L in TCGA pan-cancer cohort. (B–C) Kaplan–Meier survival analysis showed OS (B) and DFS (C) in all pan-cancer patients divided by NCBP2 altered or unaltered groups. (D) The genomic alteration of NCBP2 in TCGA pan-cancer atlas, including mutation, amplification, deep deletion and multiple alterations.
Direct Immunofluorescence Staining Cells Lyse/No Wash Procedure, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/direct immunofluorescence staining cells lyse/no-wash procedure/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
direct immunofluorescence staining cells lyse/no-wash procedure - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Genomic alteration profiles of NCBP1, NCBP2, NCBP3, NCBP2-AS1, NCBP2AS2 and NCBP2L in TCGA pan-cancer cohort. (B–C) Kaplan–Meier survival analysis showed OS (B) and DFS (C) in all pan-cancer patients divided by NCBP2 altered or unaltered groups. (D) The genomic alteration of NCBP2 in TCGA pan-cancer atlas, including mutation, amplification, deep deletion and multiple alterations.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) Genomic alteration profiles of NCBP1, NCBP2, NCBP3, NCBP2-AS1, NCBP2AS2 and NCBP2L in TCGA pan-cancer cohort. (B–C) Kaplan–Meier survival analysis showed OS (B) and DFS (C) in all pan-cancer patients divided by NCBP2 altered or unaltered groups. (D) The genomic alteration of NCBP2 in TCGA pan-cancer atlas, including mutation, amplification, deep deletion and multiple alterations.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Mutagenesis, Amplification

(A) The relative mRNA expression level of NCBP2 between tumor and normal tissues in pan-cancer from TCGA cohort. (B) The expression of NCBP2 in several cancer cell lines, including U-251, A-431, U2-OS, PC3 and MCF7 were detected by immunofluorescent staining in Human Protein Atlas. (C–F) The protein expression of NCBP2 in LUSC (C), KIRP (D), PAAD (E) and KIRC (F) and paired normal tissues were detected by immunohistochemical stain. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) The relative mRNA expression level of NCBP2 between tumor and normal tissues in pan-cancer from TCGA cohort. (B) The expression of NCBP2 in several cancer cell lines, including U-251, A-431, U2-OS, PC3 and MCF7 were detected by immunofluorescent staining in Human Protein Atlas. (C–F) The protein expression of NCBP2 in LUSC (C), KIRP (D), PAAD (E) and KIRC (F) and paired normal tissues were detected by immunohistochemical stain. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing, Staining, Immunohistochemical staining

(A) The correlation between NCBP2 and patients’ OS were shown by forest plot. (B–G) Kaplan–Meier survival analysis for patients with specific cancers (UCEC, PAAD, LIHC, KIRC, KICH and KIRP) base on the expression of NCBP2. (H–M) Multivariate cox regression analyses evaluated the prognostic independence of NCBP2 and clinicopathological features regarding OS of UCEC, PAAD, LIHC, KIRC, KICH and KIRP in TCGA datasets.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) The correlation between NCBP2 and patients’ OS were shown by forest plot. (B–G) Kaplan–Meier survival analysis for patients with specific cancers (UCEC, PAAD, LIHC, KIRC, KICH and KIRP) base on the expression of NCBP2. (H–M) Multivariate cox regression analyses evaluated the prognostic independence of NCBP2 and clinicopathological features regarding OS of UCEC, PAAD, LIHC, KIRC, KICH and KIRP in TCGA datasets.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing

Differential expressed genes (DEGs) were analyzed between the top and bottom 30% NCBP2 expression subgroup for each cancer in TCGA, following hallmarks gene set enrichment analysis (GSEA) of those DEGs to investigate the NCBP2-associated cancer processes. The size of the circle represents the false discovery rate (FDR) adjusted P value of each cancer enrichment item, and the color represents the normalized enrichment score (NES) of each enrichment item.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: Differential expressed genes (DEGs) were analyzed between the top and bottom 30% NCBP2 expression subgroup for each cancer in TCGA, following hallmarks gene set enrichment analysis (GSEA) of those DEGs to investigate the NCBP2-associated cancer processes. The size of the circle represents the false discovery rate (FDR) adjusted P value of each cancer enrichment item, and the color represents the normalized enrichment score (NES) of each enrichment item.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing

(A) Heatmap showing the correlation of NCBP2 expression and stromal score, immune score, and ESTIMATE score in pan-cancer. Positive correlation in red and negative correlation in blue. (B) Heatmap showing the correlation of NCBP2 and infiltration levels of immune cells including CD4+ T cells, CAF, progenitor, Endo, Eos, HSC, Tfh, gdT, NKT, regulatory T cells (Tregs), B cells, neutrophils, monocytes, macrophages, dendritic cells, NK cells, Mast cells and CD8+ T cells in cancers. Positive correlation in red and negative correlation in blue. * p < 1.05; ** p < 0.01.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) Heatmap showing the correlation of NCBP2 expression and stromal score, immune score, and ESTIMATE score in pan-cancer. Positive correlation in red and negative correlation in blue. (B) Heatmap showing the correlation of NCBP2 and infiltration levels of immune cells including CD4+ T cells, CAF, progenitor, Endo, Eos, HSC, Tfh, gdT, NKT, regulatory T cells (Tregs), B cells, neutrophils, monocytes, macrophages, dendritic cells, NK cells, Mast cells and CD8+ T cells in cancers. Positive correlation in red and negative correlation in blue. * p < 1.05; ** p < 0.01.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing

(A) The Spearman correlation heatmap shows the correlation between the expression of NCBP2 and twenty-six immunomodulatory genes in pan-cancer. Red represents positive correlation and blue represents negative correlation. (B–C) Correlations between NCBP2 and tumor mutation burden (TMB) (B) and microsatellite instability (MSI) (C) in pan-cancer. (D) The proportion of patients who receive immunotherapy in the low- and high- NCBP2 subgroup in the IMvigor210 cohort (bladder cancer). (E) Kaplan–Meier curve of low- and high- NCBP2 subgroup in the IMvigor210 cohort. (F) The proportion of patients who receive immunotherapy in the low- and high- NCBP2 subgroup in the GSE91061 cohort (melanoma). (G) Kaplan–Meier curve of low- and high- NCBP2 subgroup in the GSE91061 cohort. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) The Spearman correlation heatmap shows the correlation between the expression of NCBP2 and twenty-six immunomodulatory genes in pan-cancer. Red represents positive correlation and blue represents negative correlation. (B–C) Correlations between NCBP2 and tumor mutation burden (TMB) (B) and microsatellite instability (MSI) (C) in pan-cancer. (D) The proportion of patients who receive immunotherapy in the low- and high- NCBP2 subgroup in the IMvigor210 cohort (bladder cancer). (E) Kaplan–Meier curve of low- and high- NCBP2 subgroup in the IMvigor210 cohort. (F) The proportion of patients who receive immunotherapy in the low- and high- NCBP2 subgroup in the GSE91061 cohort (melanoma). (G) Kaplan–Meier curve of low- and high- NCBP2 subgroup in the GSE91061 cohort. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing, Mutagenesis

(A) Heatmap exhibited the relationship between NCBP2 and stemness indices across cancers. Positive correlation in red and negative correlation in blue. (B) (upper) The relationship between NCBP2 and drug sensitivity calculated by Spearman algorithm. The color of each column represents the p value, whereas the height of each column represents the correlation coefficient. Rs represents the drug sensitivity correlated with the NCBP2 expression. (lower) Dot plot visualized the signal pathways targeted by drugs which were sensitivity (blue) or resistant (red) to the NCBP2. The signal pathways were ranked by the frequency of being targeted. * p < 1.05; ** p < 0.01.

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) Heatmap exhibited the relationship between NCBP2 and stemness indices across cancers. Positive correlation in red and negative correlation in blue. (B) (upper) The relationship between NCBP2 and drug sensitivity calculated by Spearman algorithm. The color of each column represents the p value, whereas the height of each column represents the correlation coefficient. Rs represents the drug sensitivity correlated with the NCBP2 expression. (lower) Dot plot visualized the signal pathways targeted by drugs which were sensitivity (blue) or resistant (red) to the NCBP2. The signal pathways were ranked by the frequency of being targeted. * p < 1.05; ** p < 0.01.

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Expressing

(A) Correlation analysis between NCBP2 and cancer-related functional states at single cell level according to CancerSEA dataset. (B–D) The association between NCBP2 expression and several biological process in AML (B), UM (C), RB (D). (E–G) t-SNE diagrams were used to visualize NCBP2 expression profiles in AML (E), UM (F), RB (G).

Journal: PeerJ

Article Title: NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis

doi: 10.7717/peerj.19050

Figure Lengend Snippet: (A) Correlation analysis between NCBP2 and cancer-related functional states at single cell level according to CancerSEA dataset. (B–D) The association between NCBP2 expression and several biological process in AML (B), UM (C), RB (D). (E–G) t-SNE diagrams were used to visualize NCBP2 expression profiles in AML (E), UM (F), RB (G).

Article Snippet: In order to illustrate the subcellular localization of NCBP2, immunofluorescence staining images of human cancer cell lines (U-251, A-431, U2-OS, MCF7, and PC-3) were utilized (Human Protein Atlas).

Techniques: Functional Assay, Expressing